Useful resources |
Intravenous immunoglobulins for multiple sclerosis (Cochrane Review) ABSTRACT Background: From animal experiments, there is evidence to suggest that intravenous immunoglobulins can reverse some of the disease process of central nervous system demyelination. Subsequently, clinical trials of intravenous immunoglobulins have been conducted i . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |